Search results
Results from the WOW.Com Content Network
Antiarrhythmic drug therapy to maintain sinus rhythm in patients with recurrent paroxysmal or persistent atrial fibrillation. Drugs are listed alphabetically and not in order of suggested use. *For adrenergic atrial fibrillation, beta-blockers or sotalol are the initial drugs of choice.
This topic will provide a broad overview of the classification, clinical presentation, diagnosis, management, and sequelae of AF, including new-onset AF. The initiation and maintenance of AF reflect electrophysiologic alterations in atrial myocardium. The pathophysiology of AF is discussed in detail elsewhere.
Atrial fibrillation with rapid ventricular response (RVR) is common during critical illness. In this study, we explore the comparative effectiveness of three commonly used drugs (metoprolol, diltiazem, and amiodarone) in the management of atrial fibrillation with RVR in the intensive care unit (ICU).
Without treatment, A-fib with RVR can lead to heart disease, heart failure or a stroke. Catheter ablation provides an effective, minimally invasive treatment of atrial fibrillation. The maze procedure has a success rate of 80% to 90%, and provides long-term freedom from symptoms.
AF is the most common arrhythmia in the world and accounts for significant morbidity and mortality. Over the past decade, evidence has consistently shown that the best treatment of atrial fibrillation requires multiple stakeholders committed to providing comprehensive patient-centered care.
Rhythm control – A rhythm-control strategy typically employs one or more of the following therapies to maintain sinus rhythm: • Antiarrhythmic drug therapy (see "Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Recommendations")
Your doctor will get them to you in your vein (they’ll call this intravenously) if you have AFib with RVR. The most commonly used drugs are: Esmolol (Brevibloc)